Showing results (171-180 of 196) with videos related to
Sort By:
Pageof 20
The Journal of Clinical Investigation|February 22, 2024
Ectopic expression of the transcription factor ONECUT3 drives a complex karyotype in myelodysplastic syndromesYingwan Luo, Xiaomin Feng, Wei Lang, et al.Frontiers in Pediatrics|September 23, 2022
Disrupted establishment of anaerobe and facultative anaerobe balance in preterm infants with extrauterine growth restrictionYi-E Huang, Xintian Shen, Dingding Yin, et al.Science Advances|April 17, 2024
RIPK3 deficiency blocks R-2-hydroxyglutarate-induced necroptosis in IDH-mutated AML cellsShuanghong Zhu, Yingwan Luo, Kongfei Li, et al.Hematological Oncology|February 3, 2025
Moderate-To-Severe Bone Marrow Fibrosis Is an Independent Risk Factor For Myelodysplastic Neoplasms Patients With Increased BlastsGaixiang Xu, Xingnong Ye, Yudi Zhang, et al.American Journal of Cancer Research|January 8, 2021
Impact of mutational variant allele frequency on prognosis in myelodysplastic syndromesLingxu Jiang, Lu Wang, Chuying Shen, et al.BMC Cancer|February 16, 2024
MZ1, a BRD4 inhibitor, exerted its anti-cancer effects by suppressing SDC1 in glioblastomaGen Li, Liya Ma, Chenxi Feng, et al.Journal of Cancer Research and Clinical Oncology|January 11, 2022
Predictive values of mutational variant allele frequency in overall survival and leukemic progression of myelodysplastic syndromesLingxu Jiang, Li Ye, Liya Ma, et al.Blood|March 31, 2025
IFN-γ promotes the progression of iMCD by activating inflammatory monocytesXuejiao Yin, Yi Liu, Shengnan Ding, et al.Experimental Hematology & Oncology|January 29, 2025
EZH2 inhibition induces pyroptosis via RHA-mediated S100A9 overexpression in myelodysplastic syndromesQi Zhang, Yingwan Luo, Li Ye, et al.Journal of Hematology & Oncology|August 6, 2024
Continuous therapy in HHV-8 negative Multicentric Castleman Disease and prolonged progression-free survivalYi Liu, Xuejiao Yin, Shengnan Ding, et al.Pageof 20